Ropack Inc. Acquires Pharmaceutical Facilities in Long Island, NY
(Thomson Reuters ONE) -
Expands Capabilities and Establishes US Presence
MONTREAL, Dec. 08, 2015 (GLOBE NEWSWIRE) -- Ropack Inc., provider of contract
manufacturing and packaging services for the pharmaceutical and nutraceutical
industries, announced the purchase of two pharmaceutical facilities in Long
Island, New York. The acquisition significantly expands the company's
capabilities which will now include research and development, formulation, lab
analysis and commercial and clinical manufacturing, complementing its well-
established solid oral dosage packaging and clinical study distribution.
The buildings, formerly operated by Forest Laboratories, LLC, total 213,700
square feet and are a realization of Ropack Inc.'s strategic expansion plan. "It
has been a longstanding goal to broaden our service offerings," noted Yves
Massicotte, President and CEO. "To establish a presence in the United States at
the same time makes this acquisition ideal." Activities in the US territory
will be managed through Ropack USA Inc. Mr. Massicotte added that Ropack Inc.
and Ropack USA Inc. will now be known as "Ropack Pharma Solutions."
"The purchase of these two state-of-the-art pharmaceutical facilities on Long
Island will enable Ropack Pharma Solutions to provide its current and future
customers with comprehensive solid oral dosage development, manufacturing and
packaging solutions," remarked Paul Dupont, Vice President of Marketing and
Business Development. "This acquisition will add considerable capacity and key
technologies to support projects from formulation development through
commercialization."
Ropack Inc., celebrating its 40th anniversary in 2016, operates four facilities
in Montreal, Canada, for the packaging of solid oral dosage in bottles, flip-top
vials, blister packs, stick-packs and sachets. It also is a leading Canadian
clinical trial depot. It counts among its current customers many of the largest
and most-respected companies in the pharmaceutical and nutraceutical industries.
Contact: Paul Dupont, VP Marketing and Business Development
Ropack Pharma Solutions
(514) 353-7000
info(at)ropack.com
paul.dupont(at)ropack.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ropack, Inc. via GlobeNewswire
[HUG#1972250]
Unternehmensinformation / Kurzprofil:
Datum: 08.12.2015 - 17:37 Uhr
Sprache: Deutsch
News-ID 438362
Anzahl Zeichen: 2927
contact information:
Town:
Montreal
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ropack Inc. Acquires Pharmaceutical Facilities in Long Island, NY"
steht unter der journalistisch-redaktionellen Verantwortung von
Ropack, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
